Twist Bioscience Corporation TWST Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $185.43M-19.1% | $229.13M-20.8% | $289.28M-23.9% | $380.26M-18.6% | ||
| $49.39M-1.4% | $50.08M+0.3% | $49.94M-60.5% | $126.28M+949% | ||
| $57.02M+63.4% | $34.9M-20.8% | $44.06M+23.4% | $35.71M+34.5% | ||
| $28.31M+17.6% | $24.08M-24.9% | $32.06M-18.4% | $39.31M+23.6% | ||
| $332.97M-4.0% | $346.78M-18.3% | $424.26M-28.9% | $596.48M+9.1% | ||
| $102.28M-0.2% | $102.52M-22.2% | $131.83M-5.5% | $139.44M+216% | ||
| $82.2M-4.2% | $85.81M0.0% | $85.81M0.0% | $85.81M+283% | ||
| $13.43M-7.3% | $14.48M-73.4% | $54.48M-8.8% | $59.74M+227% | ||
| $54.34M+3,463% | $1.53M— | —— | —— | ||
| $641.86M+4.5% | $614.32M-20.9% | $776.4M-19.2% | $961.38M+36.9% | ||
| $11.09M+581% | $1.63M-88.4% | $14.05M-30.1% | $20.09M+34.8% | ||
| —— | —— | —— | $3.48M— | ||
| $91.41M+28.7% | $71.01M-3.2% | $73.32M-19.1% | $90.66M+43.8% | ||
| $15M— | $0— | —— | —— | ||
| $168.9M+19.3% | $141.63M— | $0-100% | $11.69M+18.6% | ||
| 200M— | 0— | 0— | 0— | ||
| -$1.32B-6.3% | -$1.24B-20.2% | -$1.03B-24.7% | -$828.42M-35.7% | ||
| $472.96M+0.1% | $472.69M-24.2% | $623.43M-21.0% | $789.39M+35.9% | ||
| $641.86M+4.5% | $614.32M-20.9% | $776.4M-19.2% | $961.38M+36.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Twist Bioscience Corporation cover its short-term obligations?
- Its current ratio is 2.70 — current assets exceed current liabilities.
- Where does Twist Bioscience Corporation's balance sheet data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.